Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

X4 Pharmaceuticals, Inc

NASDAQ: XFOR · Life Sciences · 5 alerts · CIK 1501697

Share price
$2.83Close, Nov 16
Market cap
$289M
Shares outstanding
102.11MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All X4 Pharmaceuticals, Inc filings on SEC EDGAR ↗

10:00 AM ET 8-K
Investor Presentation

X4 Pharmaceuticals Investor Presentation

X4 Pharmaceuticals is hosting a Virtual Investor Day on October 29, 2026, to provide updates on its strategic business plans and clinical pipeline. The presentation focuses on the commercialization of mavorixafor for primary chronic neutropenia and the progress of the ongoing 4WARD Phase 3 clinical study.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.